Genmab A/S
- SEC CIK
- 0001434265
In the past year, 4 open-market purchase filings worth $7.59B and no sales.
Current role at each company
- MRUS Merus N.V.10% Owneras of Dec 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $7.59B
- 4 filings
- Sold
- –
- 0 filings
- Net
- +$7.59B
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Genmab A/S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 (view filing) | Dec 26-29 | 4 days | Genmab A/S10% Owner | PPurchaseCommon Shares, nominal value EUR 0.09 per share | +1.06M | $97.00 | +$102.4M | +1.4%73.9M after | 2 lots |
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Genmab A/S10% Owner | PPurchaseCommon Shares, nominal value EUR 0.09 per share | −75.9M | $97.00 | −$7.36B | −100.0%0 after | |
| Dec 29, 2025 (view filing) | Dec 22-26 | 7 days | Genmab A/S10% Owner | PPurchaseCommon Shares, nominal value EUR 0.09 per share | +815.4K | $97.00 | +$79.1M | +1.1%72.8M after | 4 lots |
| Dec 22, 2025 (view filing) | Dec 18-19 | 4 days | Genmab A/S10% Owner | PPurchaseCommon Shares, nominal value EUR 0.09 per share | +278.4K | $97.00 | +$27.0M | +0.4%72.0M after | 2 lots |
| Dec 18, 2025 (view filing) | Dec 16-17 | 2 days | Genmab A/S10% Owner | PPurchaseCommon Shares, nominal value EUR 0.09 per share | +271.5K | $97.00 | +$26.3M | +0.4%71.7M after | 2 lots |